Miltefosine Rescue Treatment for Visceral Leishmaniasis Relapse Patient by Anup Bastola, Mitesh Shrestha, Bimal Sharma Chalise, Abhdesh Kumar Mishra, Lina Devkota

“…Despite undergoing treatment regimens of liposomal amphotericin B (LAMB) 5 mg/kg (standard: 10 mg/kg) daily for 3 days during the first episode followed by LAMB 5 mg/kg stat and paromomycin 15 mg/kg IM for 10 days against the second episode, the patient suffered from a third relapse and was eventually treated with miltefosine 50 mg BID directly observed treatment for 28 days. …”
Get full text

Cladophialophora bantiana Cerebral Phaeohyphomycosis Complicated by Pulmonary Nocardiosis: A Tale of Two Infections by Muhammad Farhan Khaliq, Rayan E. Ihle, Christopher P. Schirtzinger

“…The patient was treated with trimethoprim-sulfamethoxazole, meropenem, voriconazole, and liposomal amphotericin in addition to partial resection of the brain mass. …”
Get full text

The Potential Application of Nanocarriers in Delivering Topical Antioxidants by Zulfan Zazuli, Rika Hartati, Cornelia Rosasepti Rowa, Sukmadjaja Asyarie, Satrialdi

“…This review focuses on utilizing several nanocarrier systems, including nanoemulsions, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and polymeric nanoparticles, for transporting antioxidants into the skin. …”
Get full text

Structural insights into HIV-2 CA lattice formation and FG-pocket binding revealed by single-particle cryo-EM by Matthew Cook, Christian Freniere, Chunxiang Wu, Faith Lozano, Yong Xiong

“…By templating the assembly of HIV-2 CA on functionalized liposomes, we report high-resolution structures of the HIV-2 CA lattice, including both CA hexamers and pentamers, alone and with peptides of host phenylalanine-glycine (FG)-motif proteins Nup153 and CPSF6. …”
Get full text

Xeroderma Pigmentosum: Man Deprived of His Right to Light by Subhash Mareddy, Jithendra Reddy, Subhas Babu, Preethi Balan

“…T4N5 and photolyase liposomal lotions are innovations in the therapy of XP. …”
Get full text

AGD1/USP10/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate can... by Hong Wang, Chunli Cui, Weiyi Li, Hui Wu, Jianjun Sha, Jiahua Pan, Wei Xue

“…Organoid models and liposomal-chitosan nanocomplex drug delivery systems showed that reducing AGD1 expression enhanced the therapeutic effect of docetaxel in CRPC. …”
Get full text

Harnessing nanotechnology for enhanced epilepsy management by V. Manasa, J. Joysa Ruby, Himadri Priya Gogoi, S. Vignesh, P. H. Anjaneya, Akhil

“…Nanocarrier systems—such as nanoparticles, micelles, and liposomes—enhance drug specificity for brain delivery, improving the therapeutic efficacy and reducing off-target toxicity. …”
Get full text

A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib by Daniel S. O’Neil, Mark A. Francescone, Karen Khan, Alobeid Bachir, Owen A. O’Connor, Ahmed Sawas

“…He was diagnosed with Bing–Neel syndrome and treated with intrathecal liposomal cytarabine, intravenous high-dose methotrexate, and rituximab without improvement. …”
Get full text

Intravitreal Devices for the Treatment of Vitreous Inflammation by John B. Christoforidis, Susie Chang, Angela Jiang, Jillian Wang, Colleen M. Cebulla

“…Finally, recently developed investigational particulate drug delivery systems in the form of liposomes, microspheres, and nanoparticles are examined.…”
Get full text

Nanocurcumin in myocardial infarction therapy: emerging trends and future directions by Mei Lv, Qing Sun, Yilin Yu, Jinwei Bao

“…Curcumin nanoparticles have been observed to successfully reduce infarct size, maintain heart function by modulating essential molecular pathways in MI. Its liposomal formulations provide sustained release and higher tissue penetration with improved pharmacokinetics and enhanced therapeutic efficacy. …”
Get full text

Possible Involvement of Liver Resident Macrophages (Kupffer Cells) in the Pathogenesis of Both Intrahepatic and Extrahepatic Inflammation by Yuki Kakinuma, Takuya Kimura, Yoshifumi Watanabe

“…Administration of clodronate liposomes resulted in the KC deletion and in the suppression of liver injury in T cell-mediated hepatitis by ConA as a local acute inflammation model, while the treatment did not influence dextran sulfate sodium- (DSS-) induced colitis featured by weight loss, intestinal shrink, and pathological observation as an ectopic local acute inflammation model. …”
Get full text

Des «nanotransporteurs» d’ADN : Repousser les limites des Nanomédicaments pour traiter le cancer by Djawad Chikh

“…Contrairement aux nano-véhicules artificiels actuels (liposomes…), où la concentration de médicament libéré dans le temps par ces véhicules peut varier grandement d’un patient à l’autre, ces transporteurs moléculaires d’ADN peuvent être programmés pour délivrer et maintenir une dose thérapeutique optimale de médicaments dans le sang tout au long du traitement, ce qui les rend plus efficaces et plus précis. …”
Get full text

Novel cisplatin-magnetoliposome complex shows enhanced antitumor activity via Hyperthermia by M. Carmen Jiménez-López, Ana Carolina Moreno-Maldonado, Natividad Martín-Morales, Francisco O’Valle, M. Ricardo Ibarra, Gerardo F. Goya, Ignacio J. Molina

“…We have developed a new, magnetically responsive nanocarrier, consisting of liposomes loaded with magnetic nanoparticles and cis-diamminedichloroplatinum (II) (CDDP), commonly known as Cisplatin. …”
Get full text

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review by Cyrus Jalili, Amir Kiani, Mohammadreza Gholami, Fariborz Bahrehmand, Sajad Fakhri, Somayeh Kakehbaraei, Seyran Kakebaraei

“…This compound can be encapsulated by several methods (e.g. polymeric nanoparticles (NPs), solid lipid nanoparticles, Micelles, and liposomes). This antioxidant compound, however, barely crosses the blood–brain barrier (BBB), thereby limiting its bioavailability and stability at the target sites in the brain. …”
Get full text

Disseminated Histoplasmosis, Pulmonary Tuberculosis, and Cytomegalovirus Disease in a Renal Transplant Recipient after Infection with SARS-CoV-2 by Carvallo-Venegas Mauricio, Fuentes-López Elsa Angélica, Andrade-Ortega Antonio de Jesús, Torres-Baranda José Rodrigo, Carrasco-Carrizosa Aldo, Cerrillos-Gutierrez José Ignacio, Andrade-Sierra Jorge

“…Management was initiated with antituberculosis medications, ganciclovir, antibiotics, and liposomal amphotericin B, and the immunosuppressants were suspended, yet the patient’s evolution was catastrophic and the outcome fatal. …”
Get full text

Oligonucleotides as a Novel Therapeutic Approach: An Innovative Area for Drug Delivery in Neurological Disorders by Yasir Qasim Almajidi, Rana Kadum Muslim, Yaseen T. khalf

“…To overcome this pitfall, this review focuses on oligonucleotide-based novel strategies including liposomes, carbon nanotubes, quantum dots, solid lipid nanoparticles, nano lipid carriers, polymeric nanoparticles, mesoporous silica, dendrimers, aptamers, nanobodies etc. …”
Get full text

Recent trends and therapeutic potential of phytoceutical‐based nanoparticle delivery systems in mitigating non‐small cell lung cancer by Adam Haysom‐McDowell, Keshav Raj Paudel, Stewart Yeung, Sofia Kokkinis, Tammam El Sherkawi, Dinesh Kumar Chellappan, Jon Adams, Kamal Dua, Gabriele De Rubis

“…The development of novel nanoparticle delivery systems such as solid lipid nanoparticles, liquid crystalline nanoparticles, and liposomes has enhanced the bioavailability and targeted delivery of pharmaceuticals and phytoceuticals. …”
Get full text

Nanotechnology-Enhanced Controlled Release Systems in Topical Therapeutics by Yohannes Teklehaimanot

“…Various types of nanoparticles, including lipid nanoparticles, nanoemulsions, nanoemulgels, cubosome liposomes, poly-meric nanoparticles, solid-lipid nanoparticles, lipid-polymer hybrid nanoparticles, and nanostructured lipid carriers, carbon nanotubes, nanocomposites, and protein nanoparticles have been explored for their ability to encapsulate drugs, prolong drug release, and enhance skin permeation as well as improve therapeutic outcomes. …”
Get full text

Multidrug-Resistant Pathogens in Burn Wound, Prevention, Diagnosis, and Therapeutic Approaches (Conventional Antimicrobials and Nanoparticles) by Jaber Hemmati, Mehdi Azizi, Babak Asghari, Mohammad Reza Arabestani

“…Also, some advances in various types of nanomaterials, including metallic nanoparticles, liposomes, hydrogels, carbon quantum dots, and solid lipid nanoparticles in burn wound healing, will be explained.…”
Get full text

Des «nanotransporteurs» d’ADN : Repousser les limites des Nanomédicaments pour traiter le cancer by Djawad Chikh

“…Contrairement aux nano-véhicules artificiels actuels (liposomes…), où la concentration de médicament libéré dans le temps par ces véhicules peut varier grandement d’un patient à l’autre, ces transporteurs moléculaires d’ADN peuvent être programmés pour délivrer et maintenir une dose thérapeutique optimale de médicaments dans le sang tout au long du traitement, ce qui les rend plus efficaces et plus précis. …”
Get full text